Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study.
Pape UF, Kasper S, Meiler J, Sinn M, Vogel A, Müller L, Burkhard O, Caca K, Heeg S, Büchner-Steudel P, Rodriguez-Laval V, Kühl AA, Arsenic R, Jansen H, Treasure P, Utku N.
Pape UF, et al. Among authors: treasure p.
Cancers (Basel). 2020 Oct 27;12(11):3149. doi: 10.3390/cancers12113149.
Cancers (Basel). 2020.
PMID: 33121007
Free PMC article.